Showing results for "EyePoint Pharmaceuticals"
markets
Alibaba Health Profit to Grow: Earnings Week AheadAlibaba Health's profit is expected to rise, helped by standout growth the digital business, and CSPC Pharmaceutical should see better earnings in the quarters ahead on new drug approvals. Harshita Swaminathan has more on Bloomberg Television. (Source: Bloomberg)May 26, 2024
industries
Zepbound, Ozempic for Weight Loss: Safety, Effectiveness and Shortages, ExplainedObesity is among the world’s most common health conditions, but for years medicine had few effective approaches to offer short of surgery. That’s why there’s been so much excitement about a new class of drugs that’s helping patients shed dozens of pounds at far lower risk — and generating billions in revenue for pharmaceutical companies.May 24, 2024
markets
Nvidia Stock Split Looks to Be First of Many in Tech, BofA SaysNvidia Corp. delighted investors when it announced a 10-for-1 stock split earlier this week. The move may be the start of a trend, as several prominent tech companies trade at prices high enough to tip the scales toward similar splits, according to a note from Bank of America.May 24, 2024
markets
Oasis Management on Japan Economy, Kobayashi PharmaSeth Fischer, founder and chief investment officer at Oasis Management, discusses his outlook for Japan’s macro economy and the upside potential for Kobayashi Pharmaceutical. He speaks on "Daybreak Asia" after the Sohn Hong Kong Investment Leaders Conference. (Source: Bloomberg)May 24, 2024
industries
Bayer Fights for Survival as Roundup Lawsuits Burn CashBayer AG Chief Executive Officer Bill Anderson said the wave of lawsuits over its Roundup weedkiller is an “existential” threat to the company and farmers, ratcheting up the stakes as it considers a controversial legal maneuver.May 24, 2024
markets
Fischer Sees 70% Upside if Kobayashi Pharma Engages With OasisSeth Fischer, founder and chief investment officer of Oasis Management, shares his views on Kobayashi Pharmaceutical Co., the Japanese drugmaker that recalled health supplement products which left five people dead and more than a hundred hospitalized. Fischer speaks on "Bloomberg: Daybreak Asia" in Hong Kong where he's attending the Sohn Investment Leaders Conference. (Excerpt of the full interview) (Source: Bloomberg)May 23, 2024